Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Idarubicin

DRUG

Cytosin-Arabinosid

DRUG

Etoposide

DRUG

All-trans Retinoid acid

Trial Locations (22)

1140

III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien, Vienna

6020

Department of Hematology / Oncology, University Hospital of Innsbruck, Innsbruck

22763

Medical Department III of Hematology and Oncology, General Hospital Altona, Hamburg

24116

Medical Department II, University Hospital of Kiel, Kiel

26133

Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH, Oldenburg

35392

Medical Department IV, University of Gießen, Giessen

37075

Centre of Interial Medicine, University of Göttingen, Göttingen

40225

Department of Internal Medicine Hematology, Heinrich-Heine University, Düsseldorf

47574

Department of Interial Medicine, Wilhelm-Anton-Hospital Goch, Goch

53127

Department of General Internal Medicine, University Hospital of Bonn, Bonn

54292

Hospital of Barmherzige Brüder, I Medical Department, Trier

65927

Department of Interial Medicine III, City Hospital Frankfurt Am Main - Höchst, Frankfurt

66113

Department of Hematologie and Oncology, Caritas Hospital St. Theresa Saarbrücken, Saarbrücken

66421

Department of Interial Medicine I, University Hospital of Saarland, Homburg

66538

Department of Hematology and Oncology, City Hospital Neunkirchen gGmbH, Neunkirchen

66822

Department of Interial Medicine /Hematology and Oncology, Caritas Hospital Lebach, Lebach

69120

Department of Interial Medicine V, University of Heidelberg, Heidelberg

70174

Clinikal Cetner of Stuttgart, Center of Oncology, Stuttgart

70191

Medical Department I, Clinical Center of Stuttgart, Stuttgart

76133

Medical Department II, City Hospital Karlsruhe gGmbH, Karlsruhe

80804

I. Medical Department, City Hospital München-Schwabing, München

81675

Medical Department III, Clinical Center rechts der Isar, München

All Listed Sponsors
lead

University of Ulm

OTHER

NCT00146120 - Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result | Biotech Hunter | Biotech Hunter